Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOTEGRAVIR\RILPIVIRINE for Illness: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 52 adverse event reports in the FDA FAERS database where CABOTEGRAVIR\RILPIVIRINE was used for Illness.

Most Reported Side Effects for CABOTEGRAVIR\RILPIVIRINE

Side Effect Reports % Deaths Hosp.
Product dose omission issue 655 13.0% 0 32
Injection site pain 545 10.8% 1 13
Viral load increased 428 8.5% 0 3
Off label use 366 7.3% 1 2
Pain 256 5.1% 1 11
Virologic failure 255 5.1% 0 2
Product use in unapproved therapeutic environment 239 4.8% 0 0
Pathogen resistance 202 4.0% 0 1
Product storage error 168 3.3% 0 2
Inappropriate schedule of product administration 162 3.2% 1 36
Product complaint 158 3.1% 0 0
Injection site nodule 153 3.0% 0 0
Blood hiv rna increased 125 2.5% 0 1
Fatigue 123 2.5% 2 11
Wrong technique in device usage process 109 2.2% 0 2

Other Indications for CABOTEGRAVIR\RILPIVIRINE

Product used for unknown indication (2,678) Hiv infection (2,044) Hiv test (35) Acquired immunodeficiency syndrome (19) Antiretroviral therapy (18) Hiv carrier (15) Hiv test positive (15) Asymptomatic hiv infection (14) Hiv infection cdc group iii (14) Prophylaxis against hiv infection (12)

Other Drugs Used for Illness

DUPILUMAB (4,122) MEPOLIZUMAB (372) CERTOLIZUMAB PEGOL (283) ABALOPARATIDE (179) LENALIDOMIDE (164) TERIFLUNOMIDE (153) SARILUMAB (130) CABOTEGRAVIR (117) AZTREONAM LYSINE (92) RISANKIZUMAB-RZAA (79)

Related Pages

CABOTEGRAVIR\RILPIVIRINE Full Profile All Illness Drugs CABOTEGRAVIR\RILPIVIRINE Demographics CABOTEGRAVIR\RILPIVIRINE Timeline